- Home
- Publications
- Publication Search
- Publication Details
Title
How to prevent allopurinol hypersensitivity reactions?
Authors
Keywords
-
Journal
RHEUMATOLOGY
Volume 57, Issue suppl_1, Pages i35-i41
Publisher
Oxford University Press (OUP)
Online
2017-10-23
DOI
10.1093/rheumatology/kex422
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States
- (2017) Eric Jutkowitz et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Validation of a Rapid, Robust, Inexpensive Screening Method for Detecting the HLA-B*58:01 Allele in the Prevention of Allopurinol-Induced Severe Cutaneous Adverse Reactions
- (2017) Dinh Van Nguyen et al. Allergy Asthma & Immunology Research
- 2016 updated EULAR evidence-based recommendations for the management of gout
- (2016) P Richette et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of cutaneous adverse events with febuxostat treatment in patients with skin reaction to allopurinol. A retrospective, hospital-based study of 101 patients with consecutive allopurinol and febuxostat treatment
- (2016) Thomas Bardin et al. JOINT BONE SPINE
- Impact of the HLA-B * 58:01 Allele and Renal Impairment on Allopurinol-Induced Cutaneous Adverse Reactions
- (2016) Chau Yee Ng et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout
- (2016) R L Roberts et al. PHARMACOGENOMICS JOURNAL
- New and Pipeline Drugs for Gout
- (2016) Robert T. Keenan et al. Current Rheumatology Reports
- Predicting allopurinol response in patients with gout
- (2015) Daniel F. B. Wright et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- An effective strategy to prevent allopurinol-induced hypersensitivity by HLA typing
- (2015) Jae-Woo Jung et al. GENETICS IN MEDICINE
- Febuxostat-associated drug reaction with eosinophilia and systemic symptoms (DRESS)
- (2015) H.-Y. Chou et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Genetic markers associated with cutaneous adverse drug reactions to allopurinol: a systematic review
- (2015) Samantha Jarjour et al. PHARMACOGENOMICS
- Cost-Effectiveness Analysis of HLA-B5801 Genotyping in the Treatment of Gout Patients With Chronic Renal Insufficiency in Korea
- (2015) Dong-Jin Park et al. ARTHRITIS CARE & RESEARCH
- Allopurinol Use and Risk of Fatal Hypersensitivity Reactions
- (2015) Chien-Yi Yang et al. JAMA Internal Medicine
- Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin
- (2014) Wen-Hung Chung et al. ANNALS OF THE RHEUMATIC DISEASES
- Cost-Effectiveness Analysis of HLA-B*5801 Testing in Preventing Allopurinol-Induced SJS/TEN in Thai Population
- (2014) Surasak Saokaew et al. PLoS One
- Understanding the dose-response relationship of allopurinol: predicting the optimal dosage
- (2013) Garry G. Graham et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012
- (2013) Sheena N. Ramasamy et al. DRUG SAFETY
- Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008
- (2012) Yanyan Zhu et al. AMERICAN JOURNAL OF MEDICINE
- Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinol
- (2012) Lisa K. Stamp et al. ARTHRITIS AND RHEUMATISM
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing
- (2012) M S Hershfield et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Febuxostat Hypersensitivity
- (2012) A. M. ABELES JOURNAL OF RHEUMATOLOGY
- HLA-B*58:01allele is associated with augmented risk for both mild and severe cutaneous adverse reactions induced by allopurinol in Han Chinese
- (2012) Zhi-hao Cao et al. PHARMACOGENOMICS
- Furosemide increases plasma oxypurinol without lowering serum urate--a complex drug interaction: implications for clinical practice
- (2012) L. K. Stamp et al. RHEUMATOLOGY
- 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
- (2012) Dinesh Khanna et al. ARTHRITIS CARE & RESEARCH
- Severe Cutaneous Reactions Requiring Hospitalization in Allopurinol Initiators: A Population-Based Cohort Study
- (2012) Seoyoung C. Kim et al. ARTHRITIS CARE & RESEARCH
- Relationship Between Serum Urate and Plasma Oxypurinol in the Management of Gout: Determination of Minimum Plasma Oxypurinol Concentration to Achieve a Target Serum Urate Level
- (2011) L K Stamp et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis
- (2011) A. F. Cristallo et al. International Journal of Immunogenetics
- Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment
- (2010) Lisa K. Stamp et al. ARTHRITIS AND RHEUMATISM
- Strong association between HLA-B*5801 and allopurinol-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a Thai population
- (2009) Wichittra Tassaneeyakul et al. Pharmacogenetics and Genomics
- A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout
- (2008) M K Reinders et al. ANNALS OF THE RHEUMATIC DISEASES
- A European study of HLA-B in Stevens???Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs
- (2008) Christine Lonjou et al. Pharmacogenetics and Genomics
- HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis
- (2008) Nahoko Kaniwa et al. PHARMACOGENOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search